RESMED INC — Director's Dealing 2010

Feb 11, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-02-09

Reporting Person: Gallahue Kieran (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-02-09	ResMed Common Stock	M	20000	$23.885	Acquired	23223.897	Direct
2010-02-09	ResMed Common Stock	S	20000	$54.347	Disposed	3223.897	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-02-09	ResMed Stock Options	$23.885	M	20000	Disposed	2014-09-01	ResMed Common Stock (20000)	Direct

Footnotes

F1: Represents first date options became exercisable.

F2: This transaction was executed in multiple trades at prices ranging from $54.31 to $54.45. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F3: Previous reports aggregated all beneficially owned derivative securities. This report includes only beneficially owned derivative securities of the same class as those disposed of in this trade, meaning those that have the same grant date and exercise price.